Return
Update on cellular encapsulation
DOI:10.1111/xen.12399.png)
Abstract
En 中文
There is currently a significant disparity between the number of patients who need lifesaving transplants and the number of donated human organs. Xenotransplantation is a way to address this disparity and attempts to enable the use of xenogeneic tissues have persisted for centuries. While immunologic incompatibilities have presented a persistent impediment to their use, encapsulation may represent a way forward for the use of cell-based xenogeneic therapeutics without the need for immunosuppression. In conjunction with modern innovations such as the use of bioprinting, incorporation of immune modulating molecules into capsule membranes, and genetic engineering, the application of xenogeneic cells to treat disorders ranging from pain to liver failure is becoming increasingly realistic. The present review discusses encapsulation in the context of xenotransplantation, focusing on the current status of clinical trials, persistent issues such as antigen shedding, oxygen availability, and donor selection, and recent developments that may address these limitations.
Keywords:
macroencapsulation
microencapsulation
neurodegeneration
type 1 diabetes
xenotransplantation
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
4.1
Papers:
1.9K
Citations:
1.8K
Organization
Cited Papers
Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase-III (GnT-III) in cynomolgus monkeys
XENOTRANSPLANTATION
IF4.1
Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules
BIOMATERIALS
IF12.9

